INGREZZA: payments to doctors
Payments that named INGREZZA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $70.6M
- Providers
- 59,090
- Transactions
- 467,906
- Average per transaction
- $151
The per-transaction average — $151 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 59,090 providers the average total is $1,194, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Neurocrine Biosciences, Inc. | $70,575,905 | 100.0% |